Molecular studies have established that AITL pathogenesis involves characteristic mutations (RHOA, TET2, DNMT3A, and IDH2) (17, 18), all subject to acetylation regulation. This evidence concerns the gene RHOA and angioimmunoblastic T-cell lymphoma.